Stock NTLA INTELLIA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Intellia Therapeutics, Inc.

Equities

NTLA

US45826J1051

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-04-26 pm EDT 		5-day change 1st Jan Change
20.76 USD +3.70% Intraday chart for Intellia Therapeutics, Inc. -3.76% -31.91%
Apr. 15 Intellia Therapeutics, Inc. Appoints Michael P. Dube as Principal Accounting Officer CI
Mar. 25 Intellia Therapeutics Ends Development Agreement With Regeneron Pharmaceuticals MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Dividend / Share (DPS) - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Dividend / Share (DPS)

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. NTLA Stock
  4. Revisions Intellia Therapeutics, Inc.